Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.08% to 1,785.30 Indian rupees Monday, on what proved to be an ...

In New Jersey, new initiatives support investment and job growth in the artificial intelligence and film and digital media ...

Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal.

Sun Pharmaceuticals Industries Ltd. on Monday, March 10, said it will acquire a Nasdaq-listed immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc.

The acquisition aims to expand global skin cancer treatment access. Sun Pharma to Acquire Checkpoint Therapeutics for 355 Million (Image Courtesy: Reuters) Sun Pharmaceuticals recently announced its ...

the Sun Pharmaceutical Industries Ltd said on March 10. The deal, subject to shareholder and regulatory approvals, is expected to close in the second quarter of 2025. (Image: File/PTI) Checkpoint, a ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a US-based immunotherapy and targeted oncology company, for $355 million. The deal is in line with Sun ...

Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal involves an upfront cash payment of $4.10 per share, totaling up ...

Sun Pharma is going to acquire Checkpoint Therapeutics for an upfront cash payment of $4.10 per share, an official statement from the company revealed on Monday. The deal will come up to $355 million ...